secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANGAMO THERAPEUTICS, INC (SGMO)
CIK:        0001001233
Form:       8-K
Filed at:   2021-11-22T23:59:59+00:00
Accession:  0001628280-21-023921
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Joseph Zakrzewski resigns from Sangamo Board effective March 1, 2022
-----------------------------------------------------------------------------

- Joseph S. Zakrzewski voluntarily resigned from the Board, effective March 1, 2022.
- Resignation not due to any disagreement with the Company on operations, policies, or practices.
- No replacement announced; Board size and composition will adjust upon his departure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1001233/000162828021023921/0001628280-21-023921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1001233/000162828021023921/sgmo-20211117.htm
  HTML page:      https://secwatch.observer/filing/0001628280-21-023921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer